NH vs HDFC Pharma and Healthcare Fund

Portfolio Overlap Analysis · HDFC vs Nippon

42.6%
High Overlap
10 common stocks · Rank #2121 of 28,292 pairs
Fund A
NH
Nippon · Equity - Other
Fund B
HDFC Pharma and Healthcare Fund
HDFC · Sectoral - Pharma

Common Holdings (10)

StockWt% in NHWt% in HDFC Pharma and HealthcareOverlap
Sun Pharmaceutical Industries Limited
Pharmaceuticals & Biotechnology
21.93%9.81%9.81%
Divi's Laboratories Limited
Pharmaceuticals & Biotechnology
9.71%8.38%8.38%
Lupin Limited
Pharmaceuticals & Biotechnology
6.65%6.44%6.44%
Alkem Laboratories Limited
Pharmaceuticals & Biotechnology
3.93%6.21%3.93%
Glenmark Pharmaceuticals Limited
Pharmaceuticals & Biotechnology
3.84%6.62%3.84%
Laurus Labs Limited
Pharmaceuticals & Biotechnology
4.98%2.91%2.91%
IPCA Laboratories Limited
Pharmaceuticals & Biotechnology
2.53%4.80%2.53%
Torrent Pharmaceuticals Limited
Pharmaceuticals & Biotechnology
5.40%2.34%2.34%
Wockhardt Limited
Pharmaceuticals & Biotechnology
1.34%1.73%1.34%
Gland Pharma Limited
Pharmaceuticals & Biotechnology
1.73%1.12%1.12%

Unique to NH

  • Dr. Reddy's Laboratories Limited9.35%
  • Cipla Limited9.04%
  • Aurobindo Pharma Limited4.07%

Unique to HDFC Pharma and Healthcare

  • Max Healthcare Institute Limited6.36%
  • Aster DM Healthcare Limited5.42%
  • Anthem Biosciences Limited4.46%
  • Fortis Healthcare Limited4.02%

Sector Overlap Breakdown

Pharmaceuticals & Biotechnology
42.6% (10)

Analysis

AI-generated comparative analysis coming soon.

More comparisons for NH

More comparisons for HDFC Pharma and Healthcare

Overlap calculated on equity holdings only. Debt, government securities, and cash are excluded.